Indivior Pharmaceuticals (INDV) Current Assets (2021 - 2026)

Indivior Pharmaceuticals' Current Assets history runs 6 years deep, the most recent figure standing at $667.0 million for Q1 2026.

• In Q1 2026, Current Assets fell 24.46% year-over-year to $667.0 million; the TTM figure through Mar 2026 stood at $667.0 million (down 24.46% YoY), while the FY2025 annual figure was $652.0 million, down 21.16% from the prior year.
• Current Assets was $667.0 million for Q1 2026 at Indivior Pharmaceuticals, up from $652.0 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $1.3 billion in Q4 2022 to a low of $652.0 million in Q4 2025.
• Historically, Current Assets has averaged $927.2 million across 5 years, with a median of $902.5 million in 2025.
• The sharpest annual moves came in 2023 and 2024: Current Assets fell 0.16% in 2023, then sank 34.21% in 2024.
• A 5-year view of Current Assets shows it stood at $1.3 billion in 2022, then fell by 0.16% to $1.3 billion in 2023, then tumbled by 34.21% to $827.0 million in 2024, then declined by 21.16% to $652.0 million in 2025, then rose by 2.3% to $667.0 million in 2026.
• The last three Current Assets figures came in at $667.0 million (Q1 2026), $652.0 million (Q4 2025), and $922.0 million (Q3 2025), per Business Quant data.